2018 Septic Shock Drug Development Pipeline Analysis Report- Companies, Drugs, Clinical Trials, Latest Developments in Septic Shock Market
Septic shock is a progression of sepsis condition and is life threatening in most cases. Infection which has spread to different body parts through blood is referred to as sepsis. The blood pressure in the body drops suddenly, which can result in death. Sepsis progresses to severe sepsis and then to septic shock. Symptoms include breath shortage, decline in urine volume, platelet count decrease and irregular heart beat. An estimated 1.5 million people are affected in the US per anum.
To assist researchers, investors and business development managers, VPA Research has come up with a comprehensive report on Septic Shock pipeline. The report provides insights into different therapeutic candidates in preclinical, research, discovery, NDA/IND, pre registration, phase 1, phase 2, and phase 3 trials). Drugs under development directly and through combination with other drugs are also included.
Current status, developmental phase, participating companies and entities, recent developments, orphan drug/ fast track/ other designations, drug class are provided for each Septic Shock pipeline product. Mechanism of Action and the target area of the pipeline product are also provided. Further, clinical and preclinical trials along with results of the trials are also included in the report.
In addition to complete details of each product, the report provides key trends in Septic Shock pipeline studies. The products under development are categorized according to their development phase, mechanism and company to provide detailed insights into the type of drugs being developed and the stages of development.
To assist researchers, investors and business development managers, VPA Research has come up with a comprehensive report on Septic Shock pipeline. The report provides insights into different therapeutic candidates in preclinical, research, discovery, NDA/IND, pre registration, phase 1, phase 2, and phase 3 trials). Drugs under development directly and through combination with other drugs are also included.
Current status, developmental phase, participating companies and entities, recent developments, orphan drug/ fast track/ other designations, drug class are provided for each Septic Shock pipeline product. Mechanism of Action and the target area of the pipeline product are also provided. Further, clinical and preclinical trials along with results of the trials are also included in the report.
In addition to complete details of each product, the report provides key trends in Septic Shock pipeline studies. The products under development are categorized according to their development phase, mechanism and company to provide detailed insights into the type of drugs being developed and the stages of development.
1 TABLE OF CONTENTS
1.1 List of LIST OF FIGURES
1.2 List of Tables
2 SEPTIC SHOCK PIPELINE ANALYSIS
2.1 Disease and Pipeline Overview
2.2 Septic Shock Pipeline Snapshot
2.3 Septic Shock Pipeline by Phase
2.4 Septic Shock Pipeline by Company
2.5 Septic Shock Pipeline by Mechanism of Action
3 SEPTIC SHOCK- COMPANY WISE PIPELINE ANALYSIS
Adrenomed AG
Biotest Pharmaceuticals Corporation
Ferring International Center S.A.
Hibernaid, Inc.
InflaRx GmbH
Inotrem S.A.
Leading BioSciences Inc.
Lixte Biotechnology Holdings, Inc.
Matisse Pharmaceuticals B.V.
Octapharma AG
Orion Oyj
Peptinov SAS
Sangui BioTech International
Serpin Pharma, LLC
XImmune AB
4 SEPTIC SHOCK R&D PIPELINE SNAPSHOTS
Drug wise Pipeline Details
Therapeutic Candidate Name
Originator
Co-Developer/ License Partner
Orphan Drug Designation
Development Phase
Mechanism of Action
Current Status
Ongoing Clinical Trial Details
5 RECENT DEVELOPMENTS IN SEPTIC SHOCK PIPELINE
6 APPENDIX
6.1 About VPA Research
6.2 Sources and Research Methodology
1.1 List of LIST OF FIGURES
1.2 List of Tables
2 SEPTIC SHOCK PIPELINE ANALYSIS
2.1 Disease and Pipeline Overview
2.2 Septic Shock Pipeline Snapshot
2.3 Septic Shock Pipeline by Phase
2.4 Septic Shock Pipeline by Company
2.5 Septic Shock Pipeline by Mechanism of Action
3 SEPTIC SHOCK- COMPANY WISE PIPELINE ANALYSIS
Adrenomed AG
Biotest Pharmaceuticals Corporation
Ferring International Center S.A.
Hibernaid, Inc.
InflaRx GmbH
Inotrem S.A.
Leading BioSciences Inc.
Lixte Biotechnology Holdings, Inc.
Matisse Pharmaceuticals B.V.
Octapharma AG
Orion Oyj
Peptinov SAS
Sangui BioTech International
Serpin Pharma, LLC
XImmune AB
4 SEPTIC SHOCK R&D PIPELINE SNAPSHOTS
Drug wise Pipeline Details
Therapeutic Candidate Name
Originator
Co-Developer/ License Partner
Orphan Drug Designation
Development Phase
Mechanism of Action
Current Status
Ongoing Clinical Trial Details
5 RECENT DEVELOPMENTS IN SEPTIC SHOCK PIPELINE
6 APPENDIX
6.1 About VPA Research
6.2 Sources and Research Methodology
LIST OF FIGURES
Figure 1: Septic Shock Pipeline by Phase, H2- 2018
Figure 2: Septic Shock Pipeline by Companies, H2- 2018
Figure 3: Company Wise Pipeline Drug Phases, H2- 2018
Figure 4: Septic Shock Pipeline by Mechanism of Action, H2- 2018
Figure 5: Mechanism Wise Pipeline Drug Phases, H2- 2018
Figure 1: Septic Shock Pipeline by Phase, H2- 2018
Figure 2: Septic Shock Pipeline by Companies, H2- 2018
Figure 3: Company Wise Pipeline Drug Phases, H2- 2018
Figure 4: Septic Shock Pipeline by Mechanism of Action, H2- 2018
Figure 5: Mechanism Wise Pipeline Drug Phases, H2- 2018
LIST OF TABLES
Septic Shock Pipeline by Phase, H2- 2018
Septic Shock Pipeline by Companies, H2- 2018
Septic Shock Pipeline by Mechanism of Action, H2- 2018
Table 1: Adrenomed AG Septic Shock Pipeline Drugs, H2- 2018
Table 2: Biotest Pharmaceuticals Corporation Septic Shock Pipeline Drugs, H2- 2018
Table 3: Ferring International Center S.A. Septic Shock Pipeline Drugs, H2- 2018
Table 4: Hibernaid, Inc. Septic Shock Pipeline Drugs, H2- 2018
Table 5: InflaRx GmbH Septic Shock Pipeline Drugs, H2- 2018
Table 6: Inotrem S.A. Septic Shock Pipeline Drugs, H2- 2018
Table 7: Leading BioSciences Inc. Septic Shock Pipeline Drugs, H2- 2018
Table 8: Lixte Biotechnology Holdings, Inc. Septic Shock Pipeline Drugs, H2- 2018
Table 9: Matisse Pharmaceuticals B.V. Septic Shock Pipeline Drugs, H2- 2018
Table 10: Octapharma AG Septic Shock Pipeline Drugs, H2- 2018
Table 11: Orion Oyj Septic Shock Pipeline Drugs, H2- 2018
Table 12: Peptinov SAS Septic Shock Pipeline Drugs, H2- 2018
Table 13: Sangui BioTech International Septic Shock Pipeline Drugs, H2- 2018
Table 14: Serpin Pharma, LLC Septic Shock Pipeline Drugs, H2- 2018
Table 15: XImmune AB Septic Shock Pipeline Drugs, H2- 2018
Septic Shock Pipeline by Phase, H2- 2018
Septic Shock Pipeline by Companies, H2- 2018
Septic Shock Pipeline by Mechanism of Action, H2- 2018
Table 1: Adrenomed AG Septic Shock Pipeline Drugs, H2- 2018
Table 2: Biotest Pharmaceuticals Corporation Septic Shock Pipeline Drugs, H2- 2018
Table 3: Ferring International Center S.A. Septic Shock Pipeline Drugs, H2- 2018
Table 4: Hibernaid, Inc. Septic Shock Pipeline Drugs, H2- 2018
Table 5: InflaRx GmbH Septic Shock Pipeline Drugs, H2- 2018
Table 6: Inotrem S.A. Septic Shock Pipeline Drugs, H2- 2018
Table 7: Leading BioSciences Inc. Septic Shock Pipeline Drugs, H2- 2018
Table 8: Lixte Biotechnology Holdings, Inc. Septic Shock Pipeline Drugs, H2- 2018
Table 9: Matisse Pharmaceuticals B.V. Septic Shock Pipeline Drugs, H2- 2018
Table 10: Octapharma AG Septic Shock Pipeline Drugs, H2- 2018
Table 11: Orion Oyj Septic Shock Pipeline Drugs, H2- 2018
Table 12: Peptinov SAS Septic Shock Pipeline Drugs, H2- 2018
Table 13: Sangui BioTech International Septic Shock Pipeline Drugs, H2- 2018
Table 14: Serpin Pharma, LLC Septic Shock Pipeline Drugs, H2- 2018
Table 15: XImmune AB Septic Shock Pipeline Drugs, H2- 2018
